Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis

Gynecologic Oncology

Volumn 134, Issue 2, 2014, Pages 257-261

  Petrillo, M ^a   Pedone Anchora, L ^a   Tortorella, L ^a   Fanfani, F ^a   Gallotta, V ^a   Pacciani, M ^b   Scambia, G ^a   Fagotti, A ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Isolated platinum resistant relapse; Ovarian cancer; Secondary cytoreductive surgery

Indexed keywords

ISOLATED PLATINUM-RESISTANT RELAPSE; OVARIAN CANCER; SECONDARY CYTOREDUCTIVE SURGERY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARBOPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84905592752     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.05.029     Document Type: Article

References (21)

1. T. Al Rawahi, A.D. Lopes, and R.E. Bristow et al. Surgical cytoreduction for recurrent epithelial ovarian cancer Cochrane Database Syst Rev 2 2013 Feb 28 CD008765
2. R.E. Bristow, I. Puri, and D.S. Chi Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis Gynecol Oncol 112 2009 265 274
3. P. Harter, B. Beutel, and P.F. Alesina et al. Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancer Gynecol Oncol 132 2014 537 541
4. M. Petrillo, A. Fagotti, and G. Ferrandina et al. Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors Gynecol Oncol 131 2013 36 41
5. R. Salani, A. Santillan, and M.L. Zahurak et al. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome Cancer 109 2007 685 691
6. J.F. Magrina, R.L. Cetta, Y.H. Chang, G. Guevara, and P.M. Magtibay Analysis of secondary cytoreduction for recurrent ovarian cancer by robotics, laparoscopy and laparotomy Gynecol Oncol 129 2013 336 340
7. A. Fagotti, M. Petrillo, and B. Costantini et al. Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series Gynecol Oncol 132 2014 303 306
8. V. Gallotta, A. Fagotti, and F. Fanfani et al. Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience Surg Endosc 28 2014 1808 1815
9. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Ovarian Cancer Version 1.2014 Available online at http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp#ovarian [last access 28th February 2014]
10. N. Bakrin, E. Cotte, and F. Golfier et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients Ann Surg Oncol 19 2012 4052 4058
11. N. Bakrin, J.M. Bereder, and E. Decullier et al. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients Eur J Surg Oncol 39 2013 1435 1443
12. G. Ferrandina, F. Legge, V. Salutari, A. Paglia, A. Testa, and G. Scambia Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations Eur J Cancer 42 2006 2296-1302
13. F.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations Am J Stat Assoc 53 1958 457 481
14. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 1966 163 170
15. D.R. Cox Regression models and life tables J R Stat Soc 34 1972 197 220
16. R.E. Kimball, J.B. Schlaerth, and T.E. Kute et al. Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: clinical and biologic significance Am J Obstet Gynecol 176 6 1997 1319 1326 [discussion 1326-7]
17. D. Fukumura, and R.K. Jain Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization Microvasc Res 74 2007 72 84
18. R.K. Jain Delivery of molecular and cellular medicine to solid tumors Adv Drug Deliv Rev 46 2001 149 168
19. J.H. Goldie, and A.J. Coldman A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate Cancer Treat Rep 63 1979 1727 1733
20. H.K. Pannu, C. Cohade, R.E. Bristow, E.K. Fishman, and R.L. Wahl PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation Abdom Imaging 29 2004 398 403
21. R.E. Bristow, F. Simpkins, H.K. Pannu, E.K. Fishman, and F.J. Montz Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancer Gynecol Oncol 85 2002 196 200